Alternative strategies for anti-HIV treatmentERON, Joseph J; VERNAZZA, Pietro.AIDS (Supplement). 2001, Vol 15, pp S161-S169, issn 1350-2840, SUP5Article

Novel therapies based on mechanisms of HIV-1 cell entryKILBY, J. Michael; ERON, Joseph J.The New England journal of medicine. 2003, Vol 348, Num 22, pp 2228-2238, issn 0028-4793, 11 p.Article

Managing Antiretroviral Therapy : Changing Regimens, Resistance Testing, and the Risks from Structured Treatment InterruptionsERON, Joseph J.The Journal of infectious diseases. 2008, Vol 197, issn 0022-1899, S261-S271, SUP3Article

Advanced immunosuppression at entry to HIV care in the southeastern United States and associated risk factorsGAY, Cynthia L; NAPRAVNIK, Sonia; ERON, Joseph J et al.AIDS (London). 2006, Vol 20, Num 5, pp 775-778, issn 0269-9370, 4 p.Article

Effect of hepatitis C coinfection on discontinuation and modification of initial HAART in primary HIV careHOOSHYAR, Dina; NAPRAVNIK, Sonia; MILLER, William C et al.AIDS (London). 2006, Vol 20, Num 4, pp 575-583, issn 0269-9370, 9 p.Article

Pre-Exposure Prophylaxis and Antiretroviral Resistance: HIV Prevention at a Cost?HURT, Christopher B; ERON, Joseph J; COHEN, Myron S et al.Clinical infectious diseases. 2011, Vol 53, Num 12, pp 1265-1270, issn 1058-4838, 6 p.Article

Gender difference in HIV RNA levels: A meta-analysis of published studiesNAPRAVNIK, Sonia; POOLE, Charles; THOMAS, James C et al.Journal of acquired immune deficiency syndromes (1999). 2002, Vol 31, Num 1, pp 11-19, issn 1525-4135, 9 p.Article

HIV-1 drug resistance evolution among patients on potent combination antiretroviral therapy with detectable viremiaNAPRAVNIK, Sonia; EDWARDS, David; STEWART, Paul et al.Journal of acquired immune deficiency syndromes (1999). 2005, Vol 40, Num 1, pp 34-40, issn 1525-4135, 7 p.Article

Incidence and etiology of acute renal failure among ambulatory HIV-infected patientsFRANCESCHINI, Nora; NAPRAVNIK, Sonia; ERON, Joseph J et al.Kidney international. 2005, Vol 67, Num 4, pp 1526-1531, issn 0085-2538, 6 p.Article

Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapyPENCE, Brian Wells; MILLER, William C; GAYNES, Bradley N et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 44, Num 2, pp 159-166, issn 1525-4135, 8 p.Article

Opportunities for sexual transmission of antiretroviral drug resistance among HIV-infected patients in careSOETERS, Heidi M; NAPRAVNIK, Sonia; ZAKHAROVA, Oksana M et al.AIDS (London). 2013, Vol 27, Num 18, pp 2873-2881, issn 0269-9370, 9 p.Article

Clinical Presentation, Treatment, and Outcomes Among 65 Patients with HIV-Associated Lymphoma Treated at the University of North Carolina, 2000―2010GOPAL, Satish; MARTIN, Kelly E; RICHARDS, Kristy L et al.AIDS research and human retroviruses. 2012, Vol 28, Num 8, pp 798-805, issn 0889-2229, 8 p.Article

Immunosuppression, hepatitis C infection, and acute renal failure in HIV-infected patientsFRANCESCHINI, Nora; NAPRAVNIK, Sonia; FINN, William F et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 42, Num 3, pp 368-372, issn 1525-4135, 5 p.Article

Late Entry to HIV Care Among Latinos Compared With Non-Latinos in a Southeastern US CohortDENNIS, Ann M; NAPRAVNIK, Sonia; SENA, Arlene C et al.Clinical infectious diseases. 2011, Vol 53, Num 5, pp 480-487, issn 1058-4838, 8 p.Article

Enrollment, Retention, and Visit Attendance in the University of North Carolina Center for AIDS Research HIV Clinical Cohort, 2001-2007HOWE, Chanelle J; COLE, Stephen R; NAPRAVNIK, Sonia et al.AIDS research and human retroviruses. 2010, Vol 26, Num 8, pp 875-881, issn 0889-2229, 7 p.Article

Resistance to HIV Integrase Strand Transfer Inhibitors Among Clinical Specimens in the United States, 2009-2012HURT, Christopher B; SEBASTIAN, Joseph; HICKS, Charles B et al.Clinical infectious diseases. 2014, Vol 58, Num 3, pp 423-431, issn 1058-4838, 9 p.Article

HIV-1 viral load and phenotypic antiretroviral drug resistance assays based on reverse transcriptase activity in comparison to amplification based HIV-1 RNA and genotypic assaysNAPRAVNIK, Sonia; CACHAFEIRO, Ada; STEWART, Paul et al.Journal of clinical virology. 2010, Vol 47, Num 1, pp 18-22, issn 1386-6532, 5 p.Article

The effect of tuberculosis treatment on virologic and CD4⁺ cell count response to combination antiretroviral therapy: a systematic reviewSOETERS, Heidi M; NAPRAVNIK, Sonia; PATEL, Monita R et al.AIDS (London). 2014, Vol 28, Num 2, pp 245-255, issn 0269-9370, 11 p.Article

Meta-analysis of randomized trials on the association of prophylactic acyclovir and HIV-1 viral load in individuals coinfected with herpes simplex virus-2LUDEMA, Christina; COLE, Stephen R; POOLE, Charles et al.AIDS (London). 2011, Vol 25, Num 10, pp 1265-1269, issn 0269-9370, 5 p.Article

Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the southeastern United StatesPENCE, Brian Wells; MILLER, William C; WHETTEN, Kathryn et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 42, Num 3, pp 298-306, issn 1525-4135, 9 p.Article

HIV-1 Expression Within Resting CD4⁺ T Cells After Multiple Doses of VorinostatARCHIN, Nancy M; BATESON, Rosalie; RICHMAN, Douglas D et al.The Journal of infectious diseases. 2014, Vol 210, Num 5, pp 728-735, issn 0022-1899, 8 p.Article

Unexpected finding of delayed-onset seizures in HIV-positive, treatment-experienced subjects in the Phase IIb evaluation of fosdevirine (GSK2248761)MARGOLIS, David A; ERON, Joseph J; DEJESUS, Edwin et al.Antiviral therapy (London). 2014, Vol 19, Num 1, pp 69-78, issn 1359-6535, 10 p.Article

Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trialsERON, Joseph J; COOPER, David A; LOUTFY, Mona R et al.Lancet. Infectious diseases (print). 2013, Vol 13, Num 7, pp 587-596, issn 1473-3099, 10 p.Article

Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine careKALAYJIAN, Robert C; LAU, Bryan; ERON, Joseph J et al.AIDS (London). 2012, Vol 26, Num 15, pp 1907-1915, issn 0269-9370, 9 p.Article

Risk Factors for Tuberculosis After Highly Active Antiretroviral Therapy Initiation in the United States and Canada: Implications for Tuberculosis ScreeningSTERLING, Timothy R; LAU, Bryan; JOHN GILL, M et al.The Journal of infectious diseases. 2011, Vol 204, Num 6, pp 893-901, issn 0022-1899, 9 p.Article